Pieris Pharmaceuticals
PIRS
#9793
Rank
โ‚ฌ17.1 M
Marketcap
12,95ย โ‚ฌ
Share price
-15.58%
Change (1 day)
13.08%
Change (1 year)

EPS for Pieris Pharmaceuticals (PIRS)

EPS in 2023 (TTM): -0,35ย โ‚ฌ

According to Pieris Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -0,35ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,43ย โ‚ฌ an increase over its 2021 EPS that were of -0,66ย โ‚ฌ.

EPS history for Pieris Pharmaceuticals from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,35ย โ‚ฌ-17.43%
2022-0,43ย โ‚ฌ-34.78%
2021-0,66ย โ‚ฌ1.47%
2020-0,65ย โ‚ฌ23.64%
2019-0,52ย โ‚ฌ11.39%
2018-0,47ย โ‚ฌ23.44%
2017-0,38ย โ‚ฌ-25.93%
2016-0,51ย โ‚ฌ28.57%
2015-0,40ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-4,44ย โ‚ฌ 1,159.46%๐Ÿ‡บ๐Ÿ‡ธ USA
4,18ย โ‚ฌ-1,286.49%๐Ÿ‡บ๐Ÿ‡ธ USA